Effects of a sequential treatment combining estradiol valerate and estradiol valerate plus cyproterone acetate on the endothelial function in postmenopausal women;Effets d'une association sequentielle de valerate d'estradiol et d'acetate de cyproterone sur les proprietes fonctionelles de la paroi arterielle des femmes menopausees

Gynecologie Obstetrique et Fertilite

Volumn 28, Issue 7-8, 2000, Pages 509-517

  Mares, P ^a   Dauzat, M ^a   Abramovici, Y ^a   Deklunder, G ^a   Body, G ^a   Crepin, G ^a   Denis, A ^a   Favier, M ^a   Debray, J M ^a   Lebouvier, B ^a   Legrand, M S ^a   Saumet, J L ^a   Carpentier, P ^a   Lebreton, S ^a   Satger, B ^a   Gautier, C ^a   Raczka, V ^a   Ripart Neveu, S ^a   Rousseau, O ^a   Perrotin, F ^a   Tranquart, F ^a   Pourcelot, L ^a   more..

^a Schering SA   (France)

Author keywords

Cyproterone acetate; Endothelium dependant vasomotor function; Estradiol; Flow mediated dilatation; Hormone replacement therapy; Menopause; Progestin

Indexed keywords

CYPROTERONE ACETATE PLUS ESTRADIOL VALERATE; ESTRADIOL; ESTRADIOL VALERATE; FOLLITROPIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; CONJUGATED ESTROGEN; CYPROTERONE ACETATE; DRUG DERIVATIVE; PROGESTERONE DERIVATIVE;

ADULT; ARTERY BLOOD FLOW; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL WALL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HORMONE SUBSTITUTION; HUMAN; LIPID BLOOD LEVEL; POSTMENOPAUSE; VASOMOTOR REFLEX; ARTERY; DRUG EFFECT; ESTROGEN THERAPY; MIDDLE AGED; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VASODILATATION;

ARTERIES; CYPROTERONE ACETATE; ENDOTHELIUM, VASCULAR; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PROGESTERONE CONGENERS; VASODILATION;

EID: 0034217764     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Postmenopausal estrogen therapy and cardiovascular disease
2. The pathogenesis of atherosclerosis: A perspective for the 1990s
3. Re-evaluating the role of progestin therapy after the menopause
4. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease
5. The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement
6. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women
7. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in post-menopausal women. The postmenopausal estrogen/progestin interventions (PEPI) trial
8. Impact of postmenopausal hormonotherapy on cardiovascular events and cancer: Pooled data from clinical trials
9. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in posmenopausal women
10. Cardiovascular mortality and non contraceptive use of estrogen in women: Results from the lipid Research Clinics Follow-up Study
11. Estrogen and coronary heart disease in women
12. Effects of hormonal replacement on lipids and lipo-proteins in postmenopausal women
13. The protective effects of estrogen on the cardiovascular system
14. Estrogen modulates responses of atherosclerotic coronary arteries
15. Inhibition and stimulation of nitric oxyde synthesis in the human forearm arterial bed of patients with insulin-dependant diabetes
16. Non-invasive measurement of human endothelium dependant arterial responses: Accuracy and reproducibility
17. Cigarette smoking is associatd with dose-related and potentially reversible impairment of endothelium-dependant dilation in healthy young adults
18. Estrogens, progestins, and heart disease. Can endothelial function divine the benefit?
19. Comparison of transdermal and oral estrogen/progestin hormone replacement therapy: Effects on serum lipids and lipoproteins
20. Metabolic effect of two hormonal preparations in postmenopausal women
21. Use of oestradiol valerate in combination with cyproterone acetate to control menopausal symptoms: A review of efficacy, influence on endometrium, on bone metabolism and cardiovascular risk factors
22. Close relation of endothelial function in the human coronary and peripheral circulations
23. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women
24. Estrogen improves endothelium-dependent, flow-mediated vasodilatation in postmenopausal women
25. Estradiol therapy combined with progesterone and endothelium-dependant vasodilatation in postmenopausal women
26. Effect of gender differences and estrogen replacement therapy on vascular reactivity
27. Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women
28. Effect of conjugated estrogen on peripheral flow-mediated vasodilatation in postmenopausal women
29. Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women
30. Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women
31. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys